Daniel H. White
Equibles does not estimate personal net worth.
Get an email with a short summary when Clearside Biomedical, Inc. publishes a filing, an earnings call transcript or a press release.
Get CLSDQ alertsAbout Daniel H. White
Daniel H. White is recorded as CEO at Clearside Biomedical, Inc. (CLSDQ). The proxy statement of Clearside Biomedical, Inc. reports total compensation of $1,381,713 for Daniel H. White in fiscal 2019, including a base salary of $162,884. Disclosed compensation is on record for 2 fiscal years. Clearside Biomedical, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Clearside Biomedical, Inc. includes Clay B. Thorp (Chairman), Anthony S. Gibney (Board Member), Benjamin Yerxa (Board Member) and 1 other.
Affiliation history
-
Current
Company network
Leadership on record at Clearside Biomedical, Inc.
- Clay B. Thorp Chairman
- Anthony S. Gibney Board Member
- Benjamin Yerxa Board Member
- Nancy J. Hutson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Clearside Biomedical, Inc. (CLSDQ) | Former President and Chief Executive Officer | $162,884 | $1,381,713 |
| 2018 | Clearside Biomedical, Inc. (CLSDQ) | Former President and Chief Executive Officer | $482,478 | $675,122 |
Recent activity
No call appearances or filed executive changes recorded yet.